BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31476559)

  • 1. Pathological complete response after preoperative chemotherapy including FOLFOX plus bevacizumab for locally advanced rectal cancer: A case report and literature review.
    Miyamoto R; Kikuchi K; Uchida A; Ozawa M; Sano N; Tadano S; Inagawa S; Oda T; Ohkohchi N
    Int J Surg Case Rep; 2019; 62():85-88. PubMed ID: 31476559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
    Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
    Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Pathological Complete Response with Neoadjuvant Chemotherapy for Advanced Rectal Cancer].
    Okada S; Kameyama H; Abe K; Tanaka K; Oyanagi H; Nakano M; Ichikawa H; Hanyu T; Takizawa K; Nakano M; Nagahashi M; Shimada Y; Sakata J; Kobayashi T; Wakai T
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2057-2059. PubMed ID: 32157058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab.
    Yoshida T; Miki H; Satake H; Kobayashi T; Matsumi Y; Hamada M; Boku S; Shibata N; Ishida M; Sekimoto M
    Case Rep Oncol; 2021; 14(3):1497-1504. PubMed ID: 34899242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic Complete Response and Long-Term Survival After Preoperative Chemotherapy for Transverse Colon Cancer With Para-Aortic Lymph Node Metastases.
    Jimba M; Nakajima K; Momiyama M; Morikawa T; Satou S
    Cureus; 2024 Apr; 16(4):e59363. PubMed ID: 38689672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathological complete response after neoadjuvant chemotherapy with FOLFOX for locally advanced sigmoid colon cancer with diverticulitis: A case report.
    Asada Y; Chinen K; Yamataka K; Tokuyama J; Kurihara N; Iida S
    Int J Surg Case Rep; 2022 Jan; 90():106685. PubMed ID: 34952318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two cases of advanced rectal cancer resected successfully after neoadjuvant chemotherapy with FOLFOX regimen].
    Shimizu H; Taniguchi F; Sonoda H; Itokawa Y; Ikeda J; Yamashita T; Koide K; Ueshima Y; Takashina K; Lee CJ; Shioaki Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2073-5. PubMed ID: 20037327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 11. [Locally Advanced Rectal Cancer Curatively Resected after Modified FOLFOXIRI plus Bevacizumab Chemotherapy-A Case Report].
    Yamaguchi S; Kobayashi K; Inoue Y; Torashima Y; Ito S; Kanetaka K; Takatsuki M; Eguchi S
    Gan To Kagaku Ryoho; 2020 Mar; 47(3):453-455. PubMed ID: 32381914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.
    Bruera G; Giuliani A; Romano L; Chiominto A; Di Sibio A; Mastropietro S; Cosenza P; Ricevuto E; Schietroma M; Carlei F;
    BMC Cancer; 2019 Oct; 19(1):960. PubMed ID: 31619203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Locally Advanced Appendiceal Cancer with Radical Resection after CAPOX plus Bevacizumab].
    Ueda M; Ikenaga M; Tanida T; Taguchi D; Ikegami M; Fukushima S; Yoshida S; Sekiguchi N; Koh M; Iede K; Tsuda Y; Nakashima S; Matsuyama J; Yasui M; Yamada T
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1762-1764. PubMed ID: 33468821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Locally Advanced Rectal Cancer with Abscess and Rectovesical Fistula Curatively Resected Following Preoperative Chemotherapy].
    Matsumoto T; Nakanishi M; Miyamae M; Takao K; Fukunaga T; Otsuji E
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1482-1484. PubMed ID: 29394675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Complete Pathological Response in a Patient with Locally Advanced Sigmoid Colon Cancer after FOLFOX IRI Chemotherapy].
    Goto M; Okitsu H; Yuasa Y; Matsuo Y; Edagawa H; Tani R; Mori O; Kuramoto S; Tomibayashi A; Yamashita M; Fujii Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(11):1431-4. PubMed ID: 26602406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].
    Takahashi T; Namiki K; Matsumoto H; Konno F; Mitsui K; Yoshida R
    Gan To Kagaku Ryoho; 2014 May; 41(5):653-5. PubMed ID: 24917016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curative resection for locally advanced sigmoid colon cancer using neoadjuvant chemotherapy with FOLFOX plus panitumumab: A case report.
    Tomizawa K; Miura Y; Fukui Y; Hanaoka Y; Toda S; Moriyama J; Inoshita N; Ozaki Y; Takano T; Matoba S; Kuroyanagi H
    Int J Surg Case Rep; 2017; 31():128-131. PubMed ID: 28135678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological complete response of locally advanced colon cancer after preoperative radiotherapy: a case report and narrative review of the literature.
    Sekiya S; Imamura K; Takeuchi S; Teramura K; Watanabe Y; Tamoto E; Takada M; Kinoshita Y; Anbo Y; Nakamura F; Kashimura N; Noguchi H; Miura K; Hirano S
    Surg Case Rep; 2018 Jun; 4(1):58. PubMed ID: 29904815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic ileo-transverse bypass may contribute to achieving curative resection for locally advanced right colon cancer: a case report.
    Tabe S; Tonooka T; Hoshino I; Takiguchi N; Soda H; Gunji H; Nabeya Y; Ohtsuka M
    Surg Case Rep; 2021 Jun; 7(1):135. PubMed ID: 34076750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Locally Advanced Rectal Cancer Presenting with Perforation That Was Successfully Resected after Preoperative Chemotherapy with mFOLFOX6 plus Panitumumab].
    Sakabe R; Sakoda T; Yoshimura K; Murao N; Kuwada A; Tahara K; Hotei H; Maeda Y
    Gan To Kagaku Ryoho; 2019 Mar; 46(3):475-477. PubMed ID: 30914588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.